Mar 02, 2020 / 05:00PM GMT
Philip M. Nadeau - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Welcome, once again, to the Cowen and Company's 40th Annual Health Care Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to introduce the next presenting company. That's Gilead, truly one of the bellwethers of the biotech industry. We're really happy to have them with us today, particularly on a very busy day and very busy time. So we're really thankful that they made the trip all the way out to the East Coast to participate.
We have with us Merdad Parsey, who is the CMO; and Johanna Mercier, who is the CCO. I thought maybe if the 2 of you could just take a minute to introduce yourselves. You may be new to some of the people in the audience.
Johanna Mercier - Gilead Sciences, Inc. - Executive VP & Chief Commercial Officer
So good morning, good afternoon, everyone. I'm Johanna Mercier. Been at Gilead now since last July and it's been super exciting. As you can appreciate, there's been a lot going on. But more
Gilead Sciences Inc at Cowen HealthCare Conference Transcript
Mar 02, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers